AzTrials
AzTrials

Autism Spectrum DisorderNCT02751957

Pilot Study to Improve Access to Early Intervention for Autism in Africa

A study testing Early Start Denver Model in people with Autism Spectrum Disorder, run by Duke University at 1 site in South Africa.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This Mentored Career Development Award will lay the foundation for a career focused on addressing two Grand Challenges in Global Mental Health priorities: 1) improving child access to evidence-based mental health care, and 2) reducing the duration of untreated illness by developing culturally-sensitive early… Read more about this study

Who is it for?
Ages 18 to 72 months
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
Early Start Denver Model
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteSouth Africa
Study dates
1 Jul 2016to Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 72 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Diagnosis of ASD based on DSM-5 criteria by a developmental pediatrician.
  • a caretaker who speaks isiXhosa, Afrikaans or English
  • lives within an area served by the Red Cross Neurodevelopmental clinic;
  • willing to participate in the intervention and be randomized to the intervention or control group.

Who cannot join

  • a neurodevelopmental disorder of known genetic etiology (eg. Downs syndrome)
  • significant sensory or motor impairment (e.g. cerebral palsy)
  • major physical problems
  • uncontrolled seizures
  • IQ below 35 as measured by mean age equivalence score on the Griffiths Scales of Mental Development
  • unable to attend 3 assessments and 12, 1-hour, weekly consecutive intervention sessions.

Trial locations and contacts

1 site in 1 country.

South Africa1 site
  • University of Cape Town

    Cape Town, Western Cape

Other trials in South Africa

About this study

This Mentored Career Development Award will lay the foundation for a career focused on addressing two Grand Challenges in Global Mental Health priorities: 1) improving child access to evidence-based mental health care, and 2) reducing the duration of untreated illness by developing culturally-sensitive early interventions. The proposed research aims to assess implementation barriers and facilitators as well as the impact of a brief caregiver coaching early autism intervention adapted for use in a low resource setting. Data from this pilot study would inform scalable early autism intervention programs for implementation in underserved, low resource, and low-literacy populations globally.

Read the detailed description

In this proposal, the investigator's aim is to adapt the caregiver coaching version of the Early Start Denver Model (P-ESDM) and conduct a pilot study to explore the impact of this adapted intervention on child and caregiver outcomes in an African setting as well as understand key facilitators and barriers to implementation of the intervention in this setting. Importantly, this work aligns with an objective of the Federal Interagency Autism Coordinating Committee Strategic Plan: to support community-based studies that assess the effectiveness of interventions in broader community settings including scalable early intervention programs for implementation in underserved, low-resource, and low-literacy populations. The Early Start Denver Model (ESDM) was the first empirically-validated comprehensive intervention for toddlers with Autism Spectrum Disorders (ASD). In a study of P-ESDM that parallels the proposed study, Vismara et al (2009) demonstrated that in a brief 12 week, 1 hour per week, P-ESDM program with parents of toddlers with ASD, all but one parent in the study acquired mastery of the ESDM techniques at or above the 85 percent criterion by the fifth to sixth intervention session as measured by the ESDM fidelity scale. Furthermore, high levels of correct implementation of the ESDM techniques were maintained at follow-up for those parents who met fidelity and completed the program, with average percent accuracy ranging from 93-97%. The brief intervention also resulted in sustained positive growth in child social communicative behaviors. More recently, in an NIH-funded randomized controlled trial (RCT), Rogers et al (2012) found that both P-ESDM and community interventions were associated with increases in language and cognitive outcomes and decrease in ASD symptoms, despite the fact that the community intervention involved a greater number of intervention hours. Specifically, a 10-point increase in verbal developmental quotient (DQ), a 4-5 point increase in overall DQ, and a decrease in social affect symptoms on the Autism Diagnostic Observational Schedule (ADOS) were found. Moreover, the intervention resulted in lower levels of parenting stress.

The site of the proposed study is the Center for Autism Research in Africa at the University of Cape Town (Director, Prof Petrus de Vries). South Africa offers a unique opportunity to study interactions among treatment, child, family, community and context, which act as facilitators or barriers of intervention implementation, thus providing preliminary information that could help match the right treatment to the right child and family. In a recent multisite P-ESDM RCT Estes and colleagues reported that that this parent coaching intervention helped to maintain parental adjustment directly after a child was diagnosed with ASD. However, the numbers of negative life events were a significant predictor of parenting stress and sense of competence. Child and caregiver factors, particularly prevalent in South Africa (eg. poverty, malnutrition, HIV/AIDS), are known to affect child cognitive and social-emotional development, as well as parenting stress. Gathering data on the feasibility and impact of a scalable early ASD intervention in an environment where other significant child and caregiver contextual challenges exist, offers a unique opportunity to examine broader contextual factors affecting intervention implementation. The investigator will therefore document the effects of broader contextual factors (for e.g. caregiver mental health, negative life events, HIV/AIDS, and poverty) on treatment impact. In addition, this study will further the understanding of how to implement mental health early interventions in a low and middle-income country (LMIC) context, by examining processes used to train and supervise non-specialist providers who will provide the caregiver coaching in this context.

The long term goal of this proposal is to advance understanding of affordable, sustainable early intervention strategies for developmental disorders, including ASD that would benefit all families regardless of resource availability.

Specific Aim #1: Adapt the P-ESDM treatment manual and training approach. P-ESDM is a brief, scalable caregiver-mediated early autism intervention.

Specific Aim #2: Pre-pilot the adapted P-ESDM training and intervention and refine methodological details of the experimental protocol. This will provide information on the structure, content, and feasibility of the adapted P-ESDM intervention and training approach.

Specific Aim #3: Pilot of the adapted P-ESDM with preschool aged children with ASD exploring the impact on: a) child social communication abilities and overall developmental outcome, and b) implementation outcomes.

Being tested
Early Start Denver Model
Medical subject headings
Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early Start Denver ModelBehavioural

    The Early Start Denver Model is an evidence based, behavioral intervention for young children who have an autism spectrum disorder. It is a behavioral treatment informed by the principles of applied behavior analysis.

Study groups in NCT02751957
Study groupRoleWhat they receive
InterventionExperimentalReceives caregiver coaching version of the Early Start Denver Model (ESDM) intervention, delivered by non-specialist workers. ESDM is an evidence based, behavioral intervention for young children who have an autism spectrum disorder. It is a behavioral treatment informed by the principles of applied behavior analysis.
Receives: Behavioral: Early Start Denver Model

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Griffiths Scales of Mental Development: Change in developmental quotient and language subdomain developmental quotient

    The Griffiths Scales of Mental Development: a standardized developmental test for children birth to 96 months. The composite developmental quotient and the language subdomain developmental quotient will be used as outcome variables.

    Measured: Baseline, 12 week, and 16 weeks

  2. The Vineland Adaptive Behavior Scales: Changes in communication and socialization standard scores

    The Vineland Adaptive Behavior Scales, Third Edition (Vineland-3) is an individually-administered measure of adaptive behavior that is widely used to assess individuals with intellectual, developmental, and other disabilities.

    Measured: Baseline, 12 week, and 16 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Apr 2016 (estimated)
  2. Study start1 Jul 2016
  3. Primary completionJul 2020
  4. Study completionJul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02751957
Sponsor's protocol ID
Pro00064533
Status last verified
May 2020
First submitted
22 Apr 2016
Last updated
25 Aug 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Early Start Denver Model in people with Autism Spectrum Disorder, run by Duke University at 1 site in South Africa.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Africa. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Griffiths Scales of Mental Development: Change in developmental quotient and language subdomain developmental quotient (time frame: Baseline, 12 week, and 16 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in